drugset / Trial / NCT05920213
Efficacy of L-Ornithine L-Aspartate and Polyethylene Glycol in Cirrhotic Patients With Overt Hepatic Encephalopathy
RandomizedFactorialSingle-blindTreatment
Summary
The goal of this clinical trial is to compare the efficacy of L-ornithine L-aspartate and Polyethylene Glycol in Cirrhotic Patients with Overt Hepatic Encephalopathy. Participants will be asked to fill out a few questions on proforma that will obtain demographic information as well as information relating to the patient's health. Treatments that they will receive after inclusion in the study, will be the standard treatment (Lactulose) along with additional medication as part of our research (LOLA or Polyethylene glycol).
Timeline
- Start
- 2023-10
- Primary completion
- 2024-04
- Completion
- 2024-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | L-ornithine L-aspartate | Other / unclassified | 30 g | — |
| Subject | Polyethylene Glycols | Unknown | 280 g | — |
| Background | Lactulose | Other / unclassified | 60 ml | Oral |
| Background | Lactulose | Other / unclassified | 120 ml | Oral |